A. Rendón

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Ana L. Rendón, Ana Rendon, Ana Rendón, Ana Lucía Rendón
Publication record
15 papers · 909 citations · H-index 12

PAPERS

Addressing genetic diversity and health inequities: RELIVAF’s proposal for Latin American pharmacogenomic guidelines
20260 citationsauthor #14
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean
202327 citationsauthor #44
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV‐coinfected patients
200721 citationsauthor #3
Compatibility and Stability of Furosemide and Dexamethasone Combined in Infusion Solutions
20066 citationsauthor #2
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir
200626 citationsauthor #2
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
2006210 citationsauthor #11
Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.
2006132 citationsauthor #3
Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients
200582 citationsauthor #1
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.
2005193 citationsauthor #3
Pharmacogenetics in HIV therapy.
200540 citationsauthor #4
Influence of 516 G 1 T Polymorphisms at the Gene Encoding the CYP 450-2 B 6 Isoenzyme on Efavirenz Plasma Concentrations in HIV-Infected Subjects
200514 citationsauthor #3
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine
200592 citationsauthor #2
Clinical benefit of interventions driven by therapeutic drug monitoring
200537 citationsauthor #1
Combinations of nucleoside/nucleotide analogues for HIV therapy.
200429 citationsauthor #3
Diarrhea related to lopinavir is most often mild and not related to plasma drug levels.
20031 citationsauthor #1

TIMELINE

2003 1 citations

2004 29 citations

2005 458 citations

2006 374 citations

2007 21 citations

2023 27 citations

2026 0 citations

A. Rendón

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT